Pharmafile Logo
Pharmafocus logo
Advanced Search

compugen

Showing 3 posts of 3 posts found.

Gilead and Compugen enter exclusive license agreement for immunotherapy programme

December 20, 2023
Research and Development Gilead Sciences, Immunology, License Agreement, compugen, immunology

Gilead Sciences and Compugen have announced that they have entered an exclusive license agreement for Compugen’s potential first in class, …

News
medimmune_building_cambridge

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …

News

Bayer signs cancer vaccine research deal

August 6, 2013
Research and Development, Sales and Marketing Bayer, Vaccine, compugen

Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …

News
The Gateway to Local Adoption Series

Latest content

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026

Phoenix Labs acquires Kent Pharma

September 29, 2026

Astoriom acquires Sampled’s UK stability storage operations

September 28, 2026